AAAAAA

   
Results: 1-13 |
Results: 13
SELECTIVE ACTIVATION OF ADENOSINE A(3) RECEPTORS WITH -6-(3-CHLOROBENZYL)5'-N-METHYLCARBOXAMIDOADENOSINE (CB-MECA) PROVIDES CARDIOPROTECTION VIA K-ATP CHANNEL ACTIVATION
Authors: TRACEY WR MAGEE W MASAMUNE H OLEYNEK JJ HILL RJ
Citation: Wr. Tracey et al., SELECTIVE ACTIVATION OF ADENOSINE A(3) RECEPTORS WITH -6-(3-CHLOROBENZYL)5'-N-METHYLCARBOXAMIDOADENOSINE (CB-MECA) PROVIDES CARDIOPROTECTION VIA K-ATP CHANNEL ACTIVATION, Cardiovascular Research, 40(1), 1998, pp. 138-145
EVIDENCE FOR A ROLE FOR BOTH THE ADENOSINE A(1) AND A(3) RECEPTORS INPROTECTION OF ISOLATED HUMAN ATRIAL MUSCLE AGAINST SIMULATED ISCHEMIA
Authors: CARR CS HILL RJ MASAMUNE H KENNEDY SP KNIGHT DR TRACEY WR YELLON DM
Citation: Cs. Carr et al., EVIDENCE FOR A ROLE FOR BOTH THE ADENOSINE A(1) AND A(3) RECEPTORS INPROTECTION OF ISOLATED HUMAN ATRIAL MUSCLE AGAINST SIMULATED ISCHEMIA, Cardiovascular Research, 36(1), 1997, pp. 52-59
SELECTIVE ADENOSINE A(3) RECEPTOR STIMULATION REDUCES ISCHEMIC MYOCARDIAL INJURY IN THE RABBIT HEART
Authors: TRACEY WR MAGEE W MASAMUNE H KENNEDY SP KNIGHT DR BUCHHOLZ RA HILL RJ
Citation: Wr. Tracey et al., SELECTIVE ADENOSINE A(3) RECEPTOR STIMULATION REDUCES ISCHEMIC MYOCARDIAL INJURY IN THE RABBIT HEART, Cardiovascular Research, 33(2), 1997, pp. 410-415
BIARYLCARBOXYLIC-ACIDS AND BIARYLCARBOXAMIDES - INHIBITION OF PHOSPHODIESTERASE TYPE-IV VERSUS [H-3] ROLIPRAM BINDING-ACTIVITY AND THEIR RELATIONSHIP TO EMETIC BEHAVIOR IN THE FERRET
Authors: DUPLANTIER AJ BIGGERS MS CHAMBERS RJ CHENG JB COOPER K DAMON DB EGGLER JF KRAUS KG MARFAT A MASAMUNE H PILLAR JS SHIRLEY JT UMLAND JP WATSON JW
Citation: Aj. Duplantier et al., BIARYLCARBOXYLIC-ACIDS AND BIARYLCARBOXAMIDES - INHIBITION OF PHOSPHODIESTERASE TYPE-IV VERSUS [H-3] ROLIPRAM BINDING-ACTIVITY AND THEIR RELATIONSHIP TO EMETIC BEHAVIOR IN THE FERRET, Journal of medicinal chemistry, 39(1), 1996, pp. 120-125
CHARACTERIZATION OF IBMECA AS A POTENT AND SELECTIVE AGONIST OF CLONED HUMAN AND RABBIT ADENOSINE A3 RECEPTORS
Authors: HILL RJ OLEYNEK JJ KIRON MAR MASAMUNE H WENG WF BUCHHOLZ RA KNIGHT DR TRACEY WR WESTER RT KENNEDY SP
Citation: Rj. Hill et al., CHARACTERIZATION OF IBMECA AS A POTENT AND SELECTIVE AGONIST OF CLONED HUMAN AND RABBIT ADENOSINE A3 RECEPTORS, Circulation, 94(8), 1996, pp. 3217-3217
IBMECA, A SELECTIVE RABBIT ADENOSINE A3 RECEPTOR AGONIST, PHARMACOLOGICALLY PRECONDITIONS WITHOUT HEMODYNAMIC-EFFECTS, IN-SITU
Authors: SMITH AH BANGERTER FW MACANDREW JT TRACEY WR HILL RJ KENNEDY SP MASAMUNE H WIESLER RT BUCHHOLZ RA
Citation: Ah. Smith et al., IBMECA, A SELECTIVE RABBIT ADENOSINE A3 RECEPTOR AGONIST, PHARMACOLOGICALLY PRECONDITIONS WITHOUT HEMODYNAMIC-EFFECTS, IN-SITU, Circulation, 94(8), 1996, pp. 3218-3218
A PORE FOR ADENOSINE A3 RECEPTORS IN ISCHEMIC PRECONDITIONING IN THE HUMAN ATRIUM
Authors: CARR CS HILL RJ MASAMUNE H KENNEDY SP KNIGHT DR TRACEY WR YELLON DM
Citation: Cs. Carr et al., A PORE FOR ADENOSINE A3 RECEPTORS IN ISCHEMIC PRECONDITIONING IN THE HUMAN ATRIUM, Circulation, 94(8), 1996, pp. 3220-3220
SYNTHESIS AND IN-VITRO PROFILE OF 7-SUBSTITUTED QUINOLINE CHROMANOLS AS NOVEL, NONACIDIC LTB(4) ANTAGONISTS
Authors: MASAMUNE H BRESLOW R CHENG JB CONKLYN MJ EGGLER JF MARFAT A MELVIN LS PILLAR JS SHIRLEY JT SHOWELL HJ TICKNER JE
Citation: H. Masamune et al., SYNTHESIS AND IN-VITRO PROFILE OF 7-SUBSTITUTED QUINOLINE CHROMANOLS AS NOVEL, NONACIDIC LTB(4) ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(8), 1995, pp. 887-892
DISCOVERY OF MICROMOLAR PDE-IV INHIBITORS THAT EXHIBIT MUCH REDUCED AFFINITY FOR THE [H-3]ROLIPRAM BINDING-SITE - 3-NORSORNYLOXY-4-METHOXYPHENYLMETHYLENE OXINDOLES
Authors: MASAMUNE H CHENG JB COOPER K EGGLER JF MARFAT A MARSHALL SC SHIRLEY JT TICKNER JE UMLAND JP VAZQUEZ E
Citation: H. Masamune et al., DISCOVERY OF MICROMOLAR PDE-IV INHIBITORS THAT EXHIBIT MUCH REDUCED AFFINITY FOR THE [H-3]ROLIPRAM BINDING-SITE - 3-NORSORNYLOXY-4-METHOXYPHENYLMETHYLENE OXINDOLES, Bioorganic & medicinal chemistry letters, 5(17), 1995, pp. 1965-1968
SYNTHESIS AND IN-VITRO PROFILE OF A NOVEL SERIES OF CATECHOL BENZIMIDAZOLES - THE DISCOVERY OF POTENT, SELECTIVE PHOSPHODIESTERASE TYPE-IV INHIBITORS WITH GREATLY ATTENUATED AFFINITY FOR THE [H-3] ROLIPRAM BINDING-SITE
Authors: CHENG JB COOPER K DUPLANTIER AJ EGGLER JF KRAUS KG MARSHALL SC MARFAT A MASAMUNE H SHIRLEY JT TICKNER JE UMLAND JP
Citation: Jb. Cheng et al., SYNTHESIS AND IN-VITRO PROFILE OF A NOVEL SERIES OF CATECHOL BENZIMIDAZOLES - THE DISCOVERY OF POTENT, SELECTIVE PHOSPHODIESTERASE TYPE-IV INHIBITORS WITH GREATLY ATTENUATED AFFINITY FOR THE [H-3] ROLIPRAM BINDING-SITE, Bioorganic & medicinal chemistry letters, 5(17), 1995, pp. 1969-1972
SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2 NOVEL HETEROCYCLIC CHROMANOLS, CP-80,798 AND CP-85,958, AS POTENT LTD(4) RECEPTOR ANTAGONISTS
Authors: ANDREWS EG ANTOGNOLI GW BRESLOW R CARTA MP CARTY TJ CHAMBERS RJ CHENG JB COHAN VL COLLINS JL DAMON DB DELEHUNT J EGGLER JF ESKRA JD FREIERT KW HADA WA MARFAT A MASAMUNE H MELVIN LS MULARSKI CJ NACLERIO BA PAZOLES CJ PILLAR JS RAPPACH LA REICHE P RUSEK FW SHERMAN H SHIRLEY JT SWEENEY FJ TICKNER JE WATSON JW WRIGHT CF
Citation: Eg. Andrews et al., SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2 NOVEL HETEROCYCLIC CHROMANOLS, CP-80,798 AND CP-85,958, AS POTENT LTD(4) RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1365-1370
LTD(4) RECEPTOR-BINDING ACTIVITY OF NOVEL PYRIDINE CHROMANOLS - QUALITATIVE CORRELATION WITH PK(A)
Authors: MASAMUNE H EGGLER JF MARFAT A MELVIN LS RUSEK FW TICKNER JE CHENG JB SHIRLEY JT
Citation: H. Masamune et al., LTD(4) RECEPTOR-BINDING ACTIVITY OF NOVEL PYRIDINE CHROMANOLS - QUALITATIVE CORRELATION WITH PK(A), Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1371-1376
THE DISCOVERY OF CP-96,021 AND CP-96,486, BALANCED, COMBINED, POTENT AND ORALLY-ACTIVE LEUKOTRIENE D-4 (LTD(4)) PLATELET ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONISTS/
Authors: MARFAT A CHAMBERS R CHENG J COOPER K DAMON D DELEHUNT J EGGLER J MASAMUNE H MELVIN L WATSON J
Citation: A. Marfat et al., THE DISCOVERY OF CP-96,021 AND CP-96,486, BALANCED, COMBINED, POTENT AND ORALLY-ACTIVE LEUKOTRIENE D-4 (LTD(4)) PLATELET ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONISTS/, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1377-1382
Risultati: 1-13 |